Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -13.98%10.53B | ---- | -6.62%5.61B | 11.59%12.24B | 14.19%6.01B | -14.59%10.97B | -8.40%5.26B | -3.27%12.84B | --5.75B | 30.84%13.28B |
| Operating income | -13.98%10.53B | 8.06B | -6.62%5.61B | 11.59%12.24B | 14.19%6.01B | -14.59%10.97B | -8.40%5.26B | -3.27%12.84B | 5.75B | 30.84%13.28B |
| Cost of sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.58%-11B | ---4.91B | -32.22%-11.53B |
| Operating expenses | 12.99%-9.33B | 7.30%-5.02B | -12.02%-10.72B | -21.26%-5.41B | 13.00%-9.57B | 9.04%-4.46B | 4.58%-11B | -4.91B | -32.22%-11.53B | |
| Gross profit | -20.98%1.2B | -0.51%598.68M | 8.68%1.52B | -25.05%601.75M | -24.04%1.4B | -4.67%802.91M | 5.38%1.84B | 842.26M | 22.40%1.75B | |
| Selling expenses | 32.01%-890K | ---- | -1.09%-650K | 9.92%-1.31M | 11.20%-643K | 30.24%-1.45M | 37.36%-724.08K | -99.14%-2.08M | ---1.16M | -175.99%-1.05M |
| Administrative expenses | 0.68%-467.55M | ---- | -2.38%-230.11M | 8.89%-470.73M | 10.38%-224.75M | 56.62%-516.64M | 47.64%-250.77M | -8.49%-1.19B | ---478.89M | -29.73%-1.1B |
| Research and development expenses | 62.80%-220.75M | ---- | -27.60%-172.88M | -33.89%-593.41M | 26.87%-135.48M | ---443.2M | ---185.27M | ---- | ---- | ---- |
| Profit from asset sales | 113.18%2.96M | ---- | -85.35%435K | -61.56%1.39M | 125.64%2.97M | --3.61M | --1.32M | ---- | ---- | ---- |
| Revaluation surplus | 38.17%1.27M | ---- | 295.61%1.03M | 33.75%917K | -574.55%-524K | -71.91%685.62K | -91.58%110.42K | 206.66%2.44M | --1.31M | -87.36%796K |
| -Changes in the fair value of investment property | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 206.66%2.44M | --1.31M | -87.36%796K |
| -Changes in the fair value of other assets | 38.17%1.27M | ---- | 295.61%1.03M | 33.75%917K | -574.55%-524K | --685.62K | --110.42K | ---- | ---- | ---- |
| Impairment and provision | -89.58%-198.93M | ---- | 29.47%-40.37M | -19.72%-104.93M | -16.86%-57.24M | -46.13%-87.65M | -251.04%-48.98M | 25.55%-59.98M | ---13.95M | -39.32%-80.56M |
| -Other impairment is provision | -89.58%-198.93M | ---- | 29.47%-40.37M | -19.72%-104.93M | -16.86%-57.24M | -46.13%-87.65M | -251.04%-48.98M | 25.55%-59.98M | ---13.95M | -39.32%-80.56M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---195.73M | -33.65%-392.61M |
| Special items of operating profit | 114.63%14.11M | ---- | -73.04%805K | -58.78%6.58M | -54.22%2.99M | 23.05%15.95M | 149.31%6.52M | -68.51%12.96M | --2.62M | -65.82%41.16M |
| Operating profit | -10.24%294.65M | 153.16M | -19.12%142.38M | -1.91%328.28M | -42.89%176.03M | -44.63%334.68M | 96.99%308.2M | 177.39%604.47M | 156.46M | -38.90%217.91M |
| Financing income | 14.31%279.66M | ---- | 9.68%136.46M | 1.59%244.65M | 1,524.95%124.42M | --240.84M | --7.66M | ---- | ---- | ---- |
| Financing cost | -6.25%-365.91M | ---- | 7.78%-172.52M | -2.30%-344.38M | -4.41%-187.08M | 15.25%-336.64M | ---179.18M | ---397.21M | ---- | ---- |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 195.92%5.52M | --6.1M | -132.19%-5.76M |
| Special items of earning before tax | -49.10%-1.33M | ---- | 35.03%-115K | 93.22%-890K | 98.78%-177K | ---13.13M | ---14.48M | ---- | ---- | ---- |
| Earning before tax | -10.96%200.38M | 153.08M | -8.74%103.53M | -0.04%225.04M | -6.18%113.46M | 5.80%225.12M | -25.61%120.92M | 0.30%212.78M | 162.55M | -40.10%212.16M |
| Tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 48.82%-12.35M | ---26.39M | 66.47%-24.12M |
| After-tax profit from continuing operations | -7.88%193.26M | -21.94%90.35M | 2.06%209.8M | 5.00%115.74M | 2.56%205.56M | -19.04%110.23M | 6.60%200.44M | 136.16M | -33.38%188.03M | |
| Earning after tax | -7.88%193.26M | 140.41M | -21.94%90.35M | 2.06%209.8M | 5.00%115.74M | 2.56%205.56M | -19.04%110.23M | 6.60%200.44M | 136.16M | -33.38%188.03M |
| Minority profit | -2.30%54.83M | ---- | 3.03%27.07M | 10.88%56.12M | 1.95%26.27M | 2.14%50.62M | -9.47%25.77M | -21.60%49.55M | --28.46M | -4.06%63.2M |
| Profit attributable to shareholders | -9.92%138.43M | -29.27%63.28M | -0.82%153.68M | 5.93%89.47M | 2.69%154.94M | -21.57%84.46M | 20.87%150.88M | 107.69M | -42.30%124.83M | |
| Basic earnings per share | -9.09%0.1 | -28.57%0.05 | -26.67%0.11 | -12.50%0.07 | 0.00%0.15 | -27.27%0.08 | 7.14%0.15 | 0.11 | -54.84%0.14 | |
| Diluted earnings per share | -28.57%0.05 | 0.07 | 7.14%0.15 | 0.11 | -54.84%0.14 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | PwC China (Special General Partnership) | -- | -- | PwC China (Special General Partnership) | -- | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.